Description
Additionally, CK5/CK14 + AMACR (P504S) may be added to the antibody panel to assess neoplasia in prostate biopsies. Studies have shown that CK5/14 positive sporadic breast cancers arise from glandularly committed progenitor cells and represent about 9% of sporadic invasive ductal breast cancers and 78% of BRCA1-associated tumors.
Specifications
| WEIGHT | N/A |
|---|---|
| DIMENSIONS | N/A |
| INTENDED USE | RUO |
| SPECIES REACTIVITY | Human |
| SOURCE | Mouse Monoclonal |
| CLONE | XM26 + LL002 |
| ISOTYPE | IgG1, kappa + IgG3 |
| ANTIGEN | CK5 + CK14 |
| LOCALIZATION | Cytoplasmic |
| POSITIVE CONTROL | Normal prostate |
